This study introduces a supramolecular hydrogel designed to overcome a major barrier in cancer treatment by codelivering two drugs with different solubilities: one hydrophilic and one lipophilic. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback